Afrin Allergy Sinus Nasal Spray Interactions
There are 51 drugs known to interact with Afrin Allergy Sinus Nasal Spray (oxymetazoline nasal), along with 3 disease interactions. Of the total drug interactions, 6 are major, and 45 are moderate.
- View all 51 medications that may interact with Afrin Allergy Sinus Nasal Spray
- View Afrin Allergy Sinus Nasal Spray disease interactions (3)
Most frequently checked interactions
View interaction reports for Afrin Allergy Sinus Nasal Spray (oxymetazoline nasal) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- Allegra (fexofenadine)
- amlodipine
- amoxicillin
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- atorvastatin
- azelastine nasal
- baclofen
- Benadryl (diphenhydramine)
- bupropion
- Claritin (loratadine)
- Flonase (fluticasone nasal)
- fluticasone nasal
- gabapentin
- Gas-X (simethicone)
- levothyroxine
- lisinopril
- methylprednisolone
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- omeprazole
- prednisone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Afrin Allergy Sinus Nasal Spray disease interactions
There are 3 disease interactions with Afrin Allergy Sinus Nasal Spray (oxymetazoline nasal) which include:
Report options
QR code containing a link to this page
More about Afrin Allergy Sinus Nasal Spray (oxymetazoline nasal)
- Afrin Allergy Sinus Nasal Spray consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: nasal antihistamines and decongestants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.